Ethema Health Corporation (GRST)
OTCMKTS
· Delayed Price · Currency is USD
0.0004
+0.0001 (33.33%)
Apr 23, 2025, 4:00 PM EDT
Ethema Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Revenue | 5.68 | 5.34 | 4.82 | 1.94 | 0.34 | 0.36 | Upgrade
|
| Revenue Growth (YoY) | 4.05% | 10.87% | 148.16% | 473.04% | -5.82% | -16.78% | Upgrade
|
| Cost of Revenue | 3.06 | 2.66 | 1.96 | 0.71 | 0.09 | 1.28 | Upgrade
|
| Gross Profit | 2.61 | 2.69 | 2.86 | 1.23 | 0.25 | -0.92 | Upgrade
|
| Selling, General & Admin | 4.07 | 2.73 | 1.83 | 0.9 | 0.29 | 2.38 | Upgrade
|
| Other Operating Expenses | - | - | - | - | - | 0.44 | Upgrade
|
| Operating Expenses | 4.53 | 3.23 | 2.37 | 1.23 | 0.41 | 3.04 | Upgrade
|
| Operating Income | -1.91 | -0.54 | 0.49 | 0 | -0.16 | -3.96 | Upgrade
|
| Interest Expense | -0.81 | -0.78 | -1.21 | -2.8 | -1.54 | -4.42 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0 | - | 0 | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | -0.1 | 1.07 | -0.03 | -0.18 | -0.31 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.03 | -0.14 | 0.02 | 0.95 | -7.68 | -2.59 | Upgrade
|
| EBT Excluding Unusual Items | -2.7 | -1.56 | 0.36 | -1.88 | -9.55 | -11.26 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 2.48 | - | - | 0.04 | -1.02 | Upgrade
|
| Asset Writedown | - | - | - | - | - | -0.24 | Upgrade
|
| Other Unusual Items | - | -0.31 | 0.04 | 0.03 | 12.6 | -2.44 | Upgrade
|
| Pretax Income | -2.7 | 0.61 | 0.41 | -1.85 | 3.08 | -14.96 | Upgrade
|
| Income Tax Expense | -0.17 | -0.39 | 0.11 | -0.28 | - | - | Upgrade
|
| Earnings From Continuing Operations | -2.53 | 1.01 | 0.3 | -1.57 | 3.08 | -14.96 | Upgrade
|
| Net Income to Company | -2.53 | 1.01 | 0.3 | -1.57 | 3.08 | -14.96 | Upgrade
|
| Minority Interest in Earnings | 0.4 | 0.17 | -0.05 | 0.03 | - | - | Upgrade
|
| Net Income | -2.13 | 1.18 | 0.25 | -1.54 | 3.08 | -14.96 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | 0.05 | 0.1 | 0.1 | 0.05 | - | Upgrade
|
| Net Income to Common | -2.13 | 1.13 | 0.15 | -1.64 | 3.03 | -14.96 | Upgrade
|
| Net Income Growth | - | 374.66% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 4,605 | 3,729 | 3,705 | 2,702 | 1,594 | 136 | Upgrade
|
| Shares Outstanding (Diluted) | 4,605 | 3,729 | 3,705 | 2,702 | 2,045 | 136 | Upgrade
|
| Shares Change (YoY) | 23.49% | 0.65% | 37.13% | 32.08% | 1402.12% | 9.94% | Upgrade
|
| EPS (Basic) | -0.00 | 0.00 | 0.00 | -0.00 | 0.00 | -0.11 | Upgrade
|
| EPS (Diluted) | -0.00 | 0.00 | 0.00 | -0.00 | 0.00 | -0.11 | Upgrade
|
| EPS Growth | - | 655.00% | - | - | - | - | Upgrade
|
| Free Cash Flow | -0.42 | -5.78 | 1.26 | -0.22 | -0.1 | -2.99 | Upgrade
|
| Free Cash Flow Per Share | - | -0.00 | - | - | - | -0.02 | Upgrade
|
| Gross Margin | 46.03% | 50.30% | 59.29% | 63.31% | 73.88% | -255.55% | Upgrade
|
| Operating Margin | -33.71% | -10.14% | 10.15% | 0.11% | -48.19% | -1099.39% | Upgrade
|
| Profit Margin | -37.59% | 21.13% | 3.11% | -84.60% | 894.44% | -4156.96% | Upgrade
|
| Free Cash Flow Margin | -7.47% | -108.14% | 26.16% | -11.24% | -30.08% | -830.90% | Upgrade
|
| EBITDA | -1.46 | -0.04 | 1.03 | 0.33 | -0.04 | -3.74 | Upgrade
|
| EBITDA Margin | -25.66% | -0.80% | 21.35% | 16.86% | -12.41% | - | Upgrade
|
| D&A For EBITDA | 0.46 | 0.5 | 0.54 | 0.33 | 0.12 | 0.22 | Upgrade
|
| EBIT | -1.91 | -0.54 | 0.49 | 0 | -0.16 | -3.96 | Upgrade
|
| EBIT Margin | -33.71% | -10.14% | 10.15% | 0.11% | -48.19% | - | Upgrade
|
| Effective Tax Rate | - | - | 27.54% | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.